Global, Regional, and National Burden of Male Breast Cancer, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021

被引:1
作者
Wang, Long [1 ]
Wen, Ping [2 ]
Shao, Qing [1 ]
Jiang, Dongping [2 ]
Zhao, Yulan [3 ]
Zeng, Xiaohua [1 ]
机构
[1] Chongqing Univ, Canc Hosp, Dept Breast, Canc Ctr, Chongqing, Peoples R China
[2] Chongqing Univ, Canc Hosp, Sch Med, Dept Breast,Canc Ctr, Chongqing, Peoples R China
[3] Chongqing Univ, Canc Hosp, Dept Med Insurance, Chongqing, Peoples R China
关键词
epidemiology; global burden of disease study 2021; male breast cancer; risk factor; SOCIOECONOMIC INEQUALITIES; MORTALITY; SURVIVAL; TRENDS; EUROPE;
D O I
10.1002/cam4.70632
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMale breast cancer (MBC) is rare and often treated using evidence from female breast cancer (BC) trials due to limited male participation. Previous estimates lacked global coverage and completeness. We aimed to quantify the global MBC burden from 1990 to 2021 and evaluate its current status and trends.MethodsBased on the global burden of disease (GBD) database, we gathered and analyzed data on the incidence, death, and disability-adjusted life years (DALYs) of MBC while utilizing age-standardized rates (ASRs) as indicators for these measurements. Our study calculated the estimated annual percentage change (EAPC), aiming at measuring the average change in ASRs. Additionally, we evaluated the attributable risk factors (RFs) and trends of MBC across different regions and age groups worldwide.ResultsIn 2021, the global MBC age-standardized incidence rates (ASIR), age-standardized death rates (ASDR), and age-standardized DALY rates (ASDALY) per 100,000 persons were 0.941 (95% UI, 0.605-1.155), 0.335 (95% UI, 0.232-0.409), and 9.157 (95% UI, 6.116-11.423), respectively. In comparison to 1990, these rates have increased by 2.212 (95% UI, 2.047-2.378), 0.664 (95% UI, 0.562-0.767), and 0.853 (95% UI, 0.750-0.956) respectively. In Uganda 2021, the ASIR and ASDR of MBC were the highest at 4.541 (95% UI, 3.028-6.808) and 3.510 (95% UI, 2.301-5.195) per 100,000 persons, respectively. Moreover, the burden of MBC exhibited an increase with age. Globally, dietary risk was the most important attributable RF for MBC deaths, with a death percentage of 11.690% (95% UI, -0.003%-24.838%), followed by alcohol use and tobacco.ConclusionFrom 1990 to 2021, the ASIR, ASDR, and ASDALY of MBC have shown significant disparities and an increasing trend. Committing to healthy lifestyle choices, such as decreasing tobacco and alcohol consumption and making positive changes to dietary habits, can assist in reducing MBC risk. The development and execution of robust and effective public health policies are crucial for alleviating the global disease burden.
引用
收藏
页数:16
相关论文
共 47 条
[1]   Europe's beating cancer plan-a new step towards more comprehensive and equitable cancer control in Europe [J].
Albreht, Tit .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 (03) :456-457
[2]   National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019 [J].
Aryannejad, Armin ;
Moghaddam, Sahar Saeedi ;
Mashinchi, Baharnaz ;
Tabary, Mohammadreza ;
Rezaei, Negar ;
Shahin, Sarvenaz ;
Rezaei, Nazila ;
Naghavi, Mohsen ;
Larijani, Bagher ;
Farzadfar, Farshad .
BREAST CANCER RESEARCH, 2023, 25 (01)
[3]   Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials [J].
Bernhard, Juerg ;
Luo, Weixiu ;
Ribi, Karin ;
Colleoni, Marco ;
Burstein, Harold J. ;
Tondini, Carlo ;
Pinotti, Graziella ;
Spazzapan, Simon ;
Ruhstaller, Thomas ;
Puglisi, Fabio ;
Pavesi, Lorenzo ;
Parmar, Vani ;
Regan, Meredith M. ;
Pagani, Olivia ;
Fleming, Gini F. ;
Francis, Prudence A. ;
Price, Karen N. ;
Coates, Alan S. ;
Gelber, Richard D. ;
Goldhirsch, Aron ;
Walley, Barbara A. .
LANCET ONCOLOGY, 2015, 16 (07) :848-858
[4]   Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship [J].
Bhardwaj, Prarthna, V ;
Gupta, Shilpi ;
Elyash, Alexa ;
Teplinsky, Eleonora .
CURRENT ONCOLOGY REPORTS, 2024, 26 (01) :34-45
[5]   Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic [J].
Bielcikova, Zuzana ;
Holanek, Milos ;
Selingerova, Iveta ;
Sorejs, Ondrej ;
Kolarova, Iveta ;
Soumarova, Renata ;
Proks, Jan ;
Reifova, Lucie ;
Cmejlova, Vlastimila ;
Linkova, Lenka ;
Zabojnikova, Michaela ;
Chodacka, Martina ;
Janovska, Lucie ;
Lisnerova, Lenka ;
Kasparova, Karolina ;
Pohankova, Denisa ;
Petruzelka, Lubos .
ONCOLOGIST, 2024, 29 (06) :e750-e762
[6]   Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 [J].
Brauer, Michael ;
Roth, Gregory A. ;
Aravkin, Aleksandr Y. ;
Zheng, Peng ;
Abate, Kalkidan Hassen ;
Abate, Yohannes Habtegiorgis ;
Abbafati, Cristiana ;
Abbasgholizadeh, Rouzbeh ;
Abbasi, Madineh Akram ;
Abbasian, Mohammadreza ;
Abbasifard, Mitra ;
Abbasi-Kangevari, Mohsen ;
ElHafeez, Samar Abd ;
Abd-Elsalam, Sherief ;
Abdi, Parsa ;
Abdollahi, Mohammad ;
Abdoun, Meriem ;
Abdulah, Deldar Morad ;
Abdullahi, Auwal ;
Abebe, Mesfin ;
Abedi, Aidin ;
Abedi, Armita ;
Abegaz, Tadesse M. ;
Zuniga, Roberto Ariel Abeldano ;
Abiodun, Olumide ;
Abiso, Temesgen Lera ;
Aboagye, Richard Gyan ;
Abolhassani, Hassan ;
Abouzid, Mohamed ;
Aboye, Girma Beressa ;
Abreu, Lucas Guimaraes ;
Abualruz, Hasan ;
Abubakar, Bilyaminu ;
Abu-Gharbieh, Eman ;
Abukhadijah, Hana Jihad Jihad ;
Aburuz, Salahdein ;
Abu-Zaid, Ahmed ;
Adane, Mesafint Molla ;
Addo, Isaac Yeboah ;
Addolorato, Giovanni ;
Adedoyin, Rufus Adesoji ;
Adekanmbi, Victor ;
Aden, Bashir ;
Adetunji, Juliana Bunmi ;
Adeyeoluwa, Temitayo Esther ;
Adha, Rishan ;
Adibi, Amin ;
Estiningtyas, Qorinah ;
Adnani, Sakilah ;
Adzigbli, Leticia Akua .
LANCET, 2024, 403 (10440) :2162-2203
[7]   The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 [J].
Brown, Katrina F. ;
Rumgay, Harriet ;
Dunlop, Casey ;
Ryan, Margaret ;
Quartly, Frances ;
Cox, Alison ;
Deas, Andrew ;
Elliss-Brookes, Lucy ;
Gavin, Anna ;
Hounsome, Luke ;
Huws, Dyfed ;
Ormiston-Smith, Nick ;
Shelton, Jon ;
White, Ceri ;
Parkin, D. Max .
BRITISH JOURNAL OF CANCER, 2018, 118 (08) :1130-1141
[8]   Tackling the cancer burden: the economic impact of primary prevention policies [J].
Cheatley, Jane ;
Aldea, Alexandra ;
Lerouge, Alienor ;
Devaux, Marion ;
Vuik, Sabine ;
Cecchini, Michele .
MOLECULAR ONCOLOGY, 2021, 15 (03) :779-789
[9]   Older adults with cancer and common comorbidities-challenges and opportunities in improving their cancer treatment outcomes [J].
Chen, Weiwei ;
Altshuler, Rachel D. ;
Daschner, Phil ;
Morales, Carolina Salvador ;
St Germain, Diane C. ;
Guida, Jennifer ;
Prasanna, Pataje G. S. ;
Buchsbaum, Jeffrey C. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (11) :1730-1738
[10]   Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990-2017 [J].
Chen, Zhilin ;
Xu, Lu ;
Shi, Wenjie ;
Zeng, Fanyu ;
Zhuo, Rui ;
Hao, Xinbao ;
Fan, Pingming .
BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) :481-490